Skip to main content

Advertisement

Articles

Page 1 of 9

  1. High-grade glioma (HGG) is a fatal human cancer. Bortezomib, a proteasome inhibitor, has been approved for the treatment of multiple myeloma but its use in glioma awaits further investigation. This study aimed...

    Authors: Jun-Hai Tang, Lin Yang, Ju-Xiang Chen, Qing-Rui Li, Li-Rong Zhu, Qing-Fu Xu, Guo-Hao Huang, Zuo-Xin Zhang, Yan Xiang, Lei Du, Zheng Zhou and Sheng-Qing Lv

    Citation: Cancer Communications 2019 39:81

    Content type: Original article

    Published on:

  2. Clinical outcome of adrenocortical carcinoma (ACC) varies because of its heterogeneous nature and reliable prognostic prediction model for adult ACC patients is limited. The objective of this study was to deve...

    Authors: Jianqiu Kong, Junjiong Zheng, Jinhua Cai, Shaoxu Wu, Xiayao Diao, Weibin Xie, Xiong Chen, Chenyi Liao, Hao Yu, Xinxiang Fan, Chaowen Huang, Zhuowei Liu, Wei Chen, Qiang Lv, Haide Qin, Jian Huang…

    Citation: Cancer Communications 2019 39:80

    Content type: Original article

    Published on:

  3. Esophageal cancer (EC) seriously threatens human health, and a promising new avenue for EC treatment involves cancer immunotherapy. To improve the efficacy of EC immunotherapy and to develop novel strategies f...

    Authors: Tu-Xiong Huang and Li Fu

    Citation: Cancer Communications 2019 39:79

    Content type: Review

    Published on:

  4. Clinical practice has shown that Parkin is the major causative gene found in an autosomal recessive juvenile parkinsonism (AR-JP) via Parkin mutations and that the Parkin protein is the core expression product of...

    Authors: Dan Ding, Xiang Ao, Ying Liu, Yuan-Yong Wang, Hong-Ge Fa, Meng-Yu Wang, Yu-Qi He and Jian-Xun Wang

    Citation: Cancer Communications 2019 39:77

    Content type: Review

    Published on:

  5. The National Comprehensive Cancer Network guidelines recommend intensity-modulated radiotherapy (IMRT) as the primary curative treatment for newly diagnosed nasopharyngeal carcinoma (NPC), but the radiation-re...

    Authors: You-Ping Liu, Xing Lv, Xiong Zou, Yi-Jun Hua, Rui You, Qi Yang, Le Xia, Shao-Yan Guo, Wen Hu, Meng-Xia Zhang, Si-Yuan Chen, Mei Lin, Yu-Long Xie, Li-Zhi Liu, Rui Sun, Pei-Yu Huang…

    Citation: Cancer Communications 2019 39:75

    Content type: Original article

    Published on:

  6. More than 25% of patients with solid cancers develop intracerebral metastases. Aside of surgery, radiation therapy (RT) is a mainstay in the treatment of intracerebral metastases. Postoperative fractionated st...

    Authors: Christian D. Diehl, Ehab Shiban, Christoph Straube, Jens Gempt, Jan J. Wilkens, Markus Oechsner, Carmen Kessel, Claus Zimmer, Benedict Wiestler, Bernhard Meyer and Stephanie E. Combs

    Citation: Cancer Communications 2019 39:73

    Content type: Study Protocol

    Published on:

  7. Gefitinib, as the first epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI) approved for the treatment of advanced non-small cell lung cancer (NSCLC), has been proved to significantly improv...

    Authors: Zhonghan Zhang, Fan Luo, Yang Zhang, Yuxiang Ma, Shaodong Hong, Yunpeng Yang, Wenfeng Fang, Yan Huang, Li Zhang and Hongyun Zhao

    Citation: Cancer Communications 2019 39:69

    Content type: Study Protocol

    Published on:

  8. Interphase fluorescence in situ hybridization (FISH) of bone marrow cells has been confirmed to be a direct and valid method to assess the v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homo...

    Authors: Zhi-Xia Yue, Tian-Yu Xing, Chao Gao, Shu-Guang Liu, Wen Zhao, Qian Zhao, Xi-Si Wang, Mei Jin and Xiao-Li Ma

    Citation: Cancer Communications 2019 39:68

    Content type: Original article

    Published on:

  9. A growing body of evidence supports the use of laparoscopic pancreaticoduodenectomy (LPD) as an efficient and feasible surgical technique. However, few studies have investigated its applicability in pancreatic...

    Authors: Wentao Zhou, Weiwei Jin, Dansong Wang, Chao Lu, Xuefeng Xu, Renchao Zhang, Tiantao Kuang, Yucheng Zhou, Wenchuan Wu, Dayong Jin, Yiping Mou and Wenhui Lou

    Citation: Cancer Communications 2019 39:66

    Content type: Original article

    Published on:

  10. Hepatoblastoma is a rare disease that nevertheless accounts for the majority of liver malignancies in children. Due to limited epidemiological data, therapy for hepatoblastoma tends to be individualized. This ...

    Authors: Jincheng Feng, Georgios Polychronidis, Ulrike Heger, Giovanni Frongia, Arianeb Mehrabi and Katrin Hoffmann

    Citation: Cancer Communications 2019 39:62

    Content type: Original article

    Published on:

  11. Proton therapy offers dominant advantages over photon therapy due to the unique depth-dose characteristics of proton, which can cause a dramatic reduction in normal tissue doses both distal and proximal to the...

    Authors: Tai-Ze Yuan, Ze-Jiang Zhan and Chao-Nan Qian

    Citation: Cancer Communications 2019 39:61

    Content type: Mini Review

    Published on:

  12. Invasive micropapillary carcinoma (IMPC) is an uncommon subtype of breast cancer. Previous studies of this subtype demonstrated a higher propensity for lymph node metastases as compared with invasive ductal ca...

    Authors: Gary D. Lewis, Yan Xing, Waqar Haque, Tejal Patel, Mary Schwartz, Albert Chen, Andrew Farach, Sandra S. Hatch, E. Brian Butler, Jenny Chang and Bin S. Teh

    Citation: Cancer Communications 2019 39:60

    Content type: Original article

    Published on:

  13. A fixed 8-cycle oxaliplatin and capecitabine (XELOX) regimen has been the standard adjuvant therapy for patients with stage III colon cancer. However, completing the full-cycle of oxaliplatin is often associat...

    Authors: Jianhong Peng, Weihao Li, Rongxin Zhang, Junzhong Lin, Jinghua Tang, Yongshan Wen, Zhenhai Lu, Xiaojun Wu and Zhizhong Pan

    Citation: Cancer Communications 2019 39:59

    Content type: Original article

    Published on:

  14. The response rate and survival improvement for rituximab, a CD20-targeting monoclonal antibody, have been demonstrated in marginal zone lymphoma (MZL) as monotherapy and in combination with chemotherapeutic re...

    Authors: Sung Yong Oh, Won Seog Kim, Jin Seok Kim, Seok Jin Kim, Dok Hyun Yoon, Deok-Hwan Yang, Won Sik Lee, Hyo Jung Kim, Ho-Young Yhim, Seong Hyun Jeong, Jong Ho Won, Suee Lee, Jee Hyun Kong, Sung-Nam Lim, Jun Ho Ji, Kyung A. Kwon…

    Citation: Cancer Communications 2019 39:58

    Content type: Original article

    Published on:

  15. Breast cancer is a global problem, and a large number of new cases are diagnosed every year. Capecitabine is effective in patients with metastatic breast cancer (MBC). Hand-foot syndrome (HFS) is a common adve...

    Authors: Shaoyan Lin, Jian Yue, Xiuwen Guan, Peng Yuan, Jiayu Wang, Yang Luo, Ying Fan, Ruigang Cai, Qiao Li, Shanshan Chen, Pin Zhang, Qing Li, Fei Ma and Binghe Xu

    Citation: Cancer Communications 2019 39:57

    Content type: Original article

    Published on:

  16. Patients with hepatocellular carcinoma (HCC) undergoing surgical resection still have a high 5-year recurrence rate (~ 60%). With the development of laparoscopic hepatectomy (LH), few studies have compared the...

    Authors: Yang-Xun Pan, Jian-Cong Chen, Ai-Ping Fang, Xiao-Hui Wang, Jin-Bin Chen, Jun-Cheng Wang, Wei He, Yi-Zhen Fu, Li Xu, Min-Shan Chen, Yao-Jun Zhang, Qi-Jiong Li and Zhong-Guo Zhou

    Citation: Cancer Communications 2019 39:55

    Content type: Original article

    Published on:

  17. Cancer cells reprogram metabolism for proliferation. Phosphoglycerate kinase 1 (PGK1), as a glycolytic enzyme and newly identified protein kinase, coordinates glycolysis and mitochondrial metabolism. However, ...

    Authors: Fei Shao, Xueying Yang, Wei Wang, Juhong Wang, Wei Guo, Xiaoli Feng, Susheng Shi, Qi Xue, Shugeng Gao, Yibo Gao, Zhimin Lu and Jie He

    Citation: Cancer Communications 2019 39:54

    Content type: Original article

    Published on:

  18. In the original publication of this article [1], the first affiliation name in the Author details section should be updated to ‘Department of Radiation Oncology, National Cancer Center/National Clinical Resear...

    Authors: Jun-Fang Liao, Qun Zhang, Xiao-Jing Du, Mei Lan, Shan Liu, Yun-Fei Xia, Xiu-Yu Cai and Wei Luo

    Citation: Cancer Communications 2019 39:50

    Content type: Correction

    Published on:

    The original article was published in Cancer Communications 2019 39:40

  19. The optimal number of retrieved lymph nodes (LNs) in gastric cancer (GC) is still debatable and previous studies proposing new classification alternatives mostly focused on the number of retrieved LNs without ...

    Authors: Siwei Pan, Pengliang Wang, Yanan Xing, Kai Li, Zhenning Wang, Huimian Xu and Zhi Zhu

    Citation: Cancer Communications 2019 39:49

    Content type: Original article

    Published on:

  20. There is existing evidence on whether and to what degree regular exercise training improves the quality of life (QoL) among cancer survivors. However, in regards to patients with high-grade glioma (HGG; WHO gr...

    Authors: Dominik Cordier, Markus Gerber and Serge Brand

    Citation: Cancer Communications 2019 39:46

    Content type: Study Protocol

    Published on:

  21. The prevalence of Lynch syndrome and screening strategies for this disorder in Chinese patients with endometrial cancer have seldom been investigated. Such data would be essential for the screening, prevention...

    Authors: Xiaopei Chao, Lei Li, Ming Wu, Shuiqing Ma, Xianjie Tan, Sen Zhong, Yalan Bi and Jinghe Lang

    Citation: Cancer Communications 2019 39:42

    Content type: Original article

    Published on:

  22. Promising efficacy and manageable toxicity of docetaxel-based concurrent chemoradiotherapy (CCRT) were reported in head and neck cancer. In addition, the effect of CCRT in combination with cisplatin and/or 5-f...

    Authors: Jun-Fang Liao, Qun Zhang, Xiao-Jing Du, Mei Lan, Shan Liu, Yun-Fei Xia, Xiu-Yu Cai and Wei Luo

    Citation: Cancer Communications 2019 39:40

    Content type: Original article

    Published on:

    The Correction to this article has been published in Cancer Communications 2019 39:50

  23. The JACOB trial (NCT01774786) was a double-blinded, placebo-controlled, randomized, multicenter, international, phase III trial evaluating the efficacy and safety of adding pertuzumab to trastuzumab and chemot...

    Authors: Tianshu Liu, Yanru Qin, Jin Li, Ruihua Xu, Jianming Xu, Shujun Yang, Shukui Qin, Yuxian Bai, Changping Wu, Yixiang Mao, Haiyan Wu, Yilin Ge and Lin Shen

    Citation: Cancer Communications 2019 39:38

    Content type: Original article

    Published on:

  24. On May 8, 2018, the China National Medical Products Administration (NMPA) approved anlotinib, an orally administered anti-angiogenesis inhibitor, for the treatment of patients with advanced non-small cell lung...

    Authors: Ming Zhou, Xiaoyuan Chen, Hong Zhang, Lin Xia, Xin Tong, Limin Zou, Ruimin Hao, Jianhong Pan, Xiao Zhao, Dongmei Chen, Yuanyuan Song, Yueli Qi, Ling Tang, Zhifang Liu, Rong Gao, Yuankai Shi…

    Citation: Cancer Communications 2019 39:36

    Content type: Review

    Published on:

Affiliated with

Annual Journal Metrics

Advertisement